Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15888717 | 1.00 | FAAH (0.68) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL24098140 | 1.00 | FAAH (0.68) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL2749360 | 0.98 | FAAH (0.65) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL13130099 | 0.92 | FAAH (0.56) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL8537389 | 0.92 | FAAH (0.55) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL7786356 | 0.92 | FAAH (0.55) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL24934994 | 0.91 | CASP2 (0.61) | FAAHEPHX1CASP2NAAA | |
| SCHEMBL26280035 | 0.90 | FAAH (0.57) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL22856469 | 0.88 | MEN1 (0.68) | FAAHEPHX1CASP2NAAAMEN1 | |
| SCHEMBL22920352 | 0.86 | FAAH (0.53) | FAAHEPHX1CASP2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2629889-B1 | RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RES & DEV (IL) | 2019-04-03 | — | — | EP | claimed |
| US-20170283447-A1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-10-05 | — | — | US | claimed |
| EP-3188832-A1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | Yeda Research and Development Co., Ltd. (IL) | 2017-07-12 | — | — | EP | claimed |
| US-9290441-B2 | Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2016-03-22 | — | — | US | claimed |
| WO-2016035080-A1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2016-03-10 | — | — | WO | claimed |
| EP-2629889-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | Yeda Research and Development Co. Ltd. (IL) | 2013-08-28 | — | — | EP | claimed |
| US-20120253042-A1 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-10-04 | — | — | US | claimed |
| WO-2012052996-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-04-26 | — | — | WO | claimed |
| US-12145139-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-11-19 | — | — | US | disclosed |
| CN-112313239-B | Immobilized ruthenium-TRIPHOS catalysts for selective hydrogenation of amides | 伊士曼化工公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-23 | — | — | US | disclosed |
| EP-3188832-B1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | YEDA RES & DEV (IL) | 2023-10-04 | — | — | EP | disclosed |
| CN-112105623-B | Molecular catalysts for selective hydrogenolysis of amides | 伊士曼化工公司 | 2023-09-12 | — | — | CN | disclosed |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-08-22 | — | — | US | disclosed |
| US-20130281664-A1 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-10-24 | — | — | US | disclosed |
| EP-2629889-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | Yeda Research and Development Co. Ltd. (IL) | 2013-08-28 | — | — | EP | disclosed |
| US-20120253042-A1 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-10-04 | — | — | US | disclosed |
| US-20120171245-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2012052996-A2 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2012-04-26 | — | — | WO | disclosed |
| US-20090274650-A1 | INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372915-A1 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | ADH1C, OTC, MLEC | FAAH 3628/4885EPHX1 4754/4885CASP2 3267/4885 |
| US-20120253042-A1 | USE OF RUTHENIUM COMPLEXES FOR FORMATION AND/OR HYDROGENATION OF AMIDES AND RELATED CARBOXYLIC ACID DERIVATIVES | ADH5, ADH1C, ADH1A | FAAH 673/4885EPHX1 4154/4885CASP2 2859/4885 |
| US-12145139-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, MLEC | FAAH 3628/4885EPHX1 4754/4885CASP2 3267/4885 |
| US-20120171245-A1 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | ACE, IRF3, ACE2 | FAAH 1519/4885EPHX1 3137/4885CASP2 4806/4885 |
| US-20170283447-A1 | RUTHENIUM COMPLEXES AND THEIR USES AS CATALYSTS IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND RELATED REACTIONS | ADH1A, ADH1C, ADH5 | FAAH 1233/4885EPHX1 4311/4885CASP2 3574/4885 |
| US-20130281664-A1 | NOVEL RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | ADH5, ADH1C, ADH1A | FAAH 636/4885EPHX1 4472/4885CASP2 2188/4885 |
| US-11731116-B2 | Manganese based complexes and uses thereof for homogeneous catalysis | ADH1C, OTC, ADH5 | FAAH 3840/4885EPHX1 4804/4885CASP2 3459/4885 |
| US-20090274650-A1 | INHIBITORS OF ASPARTYL PROTEASE | SPINT2, DNPEP, PRSS1 | FAAH 1049/4885EPHX1 2453/4885CASP2 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.